Le Lézard
Classified in: Oil industry, Environment, Business, Covid-19 virus
Subject: ERN

Ellomay Capital Reports Results for the Three and Six Months Ended June 30, 2020


TEL AVIV, Israel, Sept. 24, 2020 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported its unaudited financial results for the three and six month periods ended June 30, 2020.

Financial Highlights

Second Quarter 2020 CEO Review

Ran Fridrich, CEO and a board member of the Company, provided the following CEO review:

Use of NON-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's historical financial performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures, and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measures presented by other companies. The Company's EBITDA may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. A reconciliation between results on an IFRS and non-IFRS basis is provided in the last table of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

Ellomay Capital is controlled by Mr. Shlomo Nehama, Mr. Hemi Raphael and Mr. Ran Fridrich. Mr. Nehama is one of Israel's prominent businessmen and the former Chairman of Israel's leading bank, Bank Hapohalim, and Messrs. Raphael and Fridrich both have vast experience in financial and industrial businesses. These controlling shareholders, along with Ellomay's dedicated professional management, accumulated extensive experience in recognizing suitable business opportunities worldwide. Ellomay believes the expertise of Ellomay's controlling shareholders and management enables the Company to access the capital markets, as well as assemble global institutional investors and other potential partners. As a result, we believe Ellomay is capable of considering significant and complex transactions, beyond its immediate financial resources.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements.  The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Financial Position



June 30,

December 31,

June 30,



2020

2019

2020



(Unaudited)

(Audited)

(Unaudited)





Convenience Translation



? in thousands

into US$ in thousands*

Assets





Current assets





Cash and cash equivalents


51,232

44,509

57,393

Marketable securities


2,226

2,242

2,494

Short term deposits


6,439

6,446

7,213

Restricted cash


-

22,162

-

Receivable from concession project


1,486

1,463

1,665

Financial assets


-

1,418

-

Trade and other receivables


4,790

4,882

5,366



66,173

83,122

74,131

Non-current assets





Investment in equity accounted investee


32,165

33,561

36,033

Advances on account of investments


882

883

988

Receivable from concession project


26,173

27,122

29,320

Fixed assets


194,521

114,389

217,913

Right-of-use asset


15,291

15,401

17,130

Intangible asset


4,857

5,042

5,441

Restricted cash and deposits


10,275

10,956

11,511

Deferred tax


5,777

2,285

6,472

Long term receivables


5,305

12,249

5,943

Derivatives


209

5,162

234



295,455

227,050

330,985

Total assets


361,628

310,172

405,116

Liabilities and Equity





Current liabilities





Current maturities of long term bank loans**


4,603

4,138

5,157

Current maturities of long term loans**


2,472

-

2,769

Debentures


4,592

26,773

5,144

Trade payables


1,730

1,765

1,940

Other payables


5,425

5,010

6,077



18,822

37,686

21,087

Non-current liabilities





Lease liability


15,487

15,402

17,349

Liabilities to banks **


110,906

**40,805

124,243

Other long-term loans **


46,711

**48,377

52,328

Debentures


40,087

44,811

44,908

Deferred tax


6,854

6,467

7,678

Other long-term liabilities


1,289

1,795

1,444

Derivatives


14,152

7,263

15,854



235,486

164,920

263,804

Total liabilities


254,308

202,606

284,891






Equity





Share capital


23,933

21,998

26,811

Share premium


75,433

64,160

84,504

Treasury shares


(1,736)

(1,736)

(1,945)

Transaction reserve with non-controlling Interests


6,106

6,106

6,840

Reserves


(1,454)

3,283

(1,629)

Retained earnings


9,346

12,818

10,470

Total equity attributed to shareholders of the Company


111,628

106,629

125,051

Non-Controlling Interest


(4,308)

937

(4,826)

Total equity


107,320

107,566

120,225

Total liabilities and equity


361,628

310,172

405,116


* Convenience translation into US$ (exchange rate as at June 30, 2020: EUR 1 = US$ 1.120)

**Reclassified

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (in thousands, except per share data)



For the three months
ended  June 30,

For the six months
ended June 30

For the year ended
December 31,

For the six months
ended June 30,



2020

2019

2020

2019

2019

2020



Unaudited

Unaudited

Audited

Unaudited






Convenience
Translation
into US$*






? in thousands

? in thousands

? in thousands


Revenues

2,271

5,570

4,214

10,303

18,988

4,721


Operating expenses

(1,085)

(1,791)

(2,146)

(3,455)

(6,638)

(2,404)


Depreciation and amortization expenses

(721)

(1,465)

(1,447)

(3,043)

(6,416)

(1,621)


Gross profit

465

2,314

621

3,805

5,934

696










Project development costs

(584)

(1,840)

(2,338)

(2,714)

(4,213)

(2,619)


General and administrative expenses

(1,123)

(982)

(2,204)

(1,879)

(3,827)

(2,469)


Share of profits of equity accounted investee

(481)

(1,133)

850

31

3,086

952


Other income (expenses), net

-

-

-

-

(2,100)

-


Capital gain

-

-

-

-

18,770

-


Operating profit (loss)

(1,723)

(1,641)

(3,071)

(757)

17,650

(3,440)










Financing income

378

480

886

870

1,827

993


Financing income in connection with derivatives and warrants, net

145

29

1,099

460

897

1,231


Financing expenses

(1,220)

(1,972)

(3,095)

(4,457)

(10,877)

(3,467)


Financing expenses, net

(697)

(1,463)

(1,110)

(3,127)

(8,153)

(1,243)


Profit (loss) before taxes on income

(2,420)

(3,104)

(4,181)

(3,884)

9,497

(4,683)


Tax benefit (Taxes on income) 

16

(325)

(88)

(514)

287

(99)


Profit (loss) for the period

(2,404)

(3,429)

(4,269)

(4,398)

9,784

(4,782)


Profit (loss) attributable to:








Owners of the Company

(2,055)

(2,040)

(3,472)

(2,751)

12,060

(3,890)


Non-controlling interests

(349)

(1,389)

(797)

(1,647)

(2,276)

(892)


Profit (loss) for the period

(2,404)

(3,429)

(4,269)

(4,398)

9,784

(4,782)


Other comprehensive income (loss) items that 








after initial recognition in comprehensive 








income (loss) were or will be transferred to profit or loss:








Foreign currency translation differences for foreign operations








113

(250)

(86)

982

2,103

(97)


Effective portion of change in fair value of cash flow hedges








(23,401)

(718)

(9,289)

(368)

1,076

(10,406)


Net change in fair value of cash flow hedges transferred to profit or loss

87

(94)

190

(1,104)

(1,922)

213


Total other comprehensive income (loss)

(23,201)

(1,062)

(9,185)

(490)

1,257

(10,290)










Total other comprehensive income (loss) attributable to:








Owners of the Company

(11,638)

(667)

(4,737)

(13)

2,114

(5,307)


Non-controlling interests

(11,563)

(395)

(4,448)

(477)

(857)

(4,983)


Total other comprehensive income (loss)

(23,201)

(1,062)

(9,185)

(490)

1,257

(10,290)










Total comprehensive income (loss) for the period

(25,605)

(4,491)

(13,454)

(4,888)

11,041

(15,072)










Total comprehensive income (loss) for the period
attributable to:








Owners of the Company

(13,693)

(2,707)

(8,209)

(2,764)

14,174

(9,197)


Non-controlling interests

(11,912)

(1,784)

(5,245)

(2,124)

(3,133)

(5,875)


Total comprehensive income (loss) for the period

(25,605)

(4,491)

(13,454)

(4,888)

11,041

(15,072)










Basic net earnings (loss) per share

(0.17)

(0.19)

(0.29)

(0.26)

1.09

(0.32)


Diluted net earnings (loss) per share

(0.17)

(0.19)

(0.29)

(0.26)

1.09

(0.32)



* Convenience translation into US$ (exchange rate as at June 30, 2020: EUR 1 = US$ 1.120)

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Unaudited Interim Statements of Changes in Equity





Attributable to shareholders of the Company

Non- controlling

Total




Interests

Equity


 

 

 

Share capital

 

 

 

Share premium

 

 

 

Retained earnings

 

 

 

Treasury shares

 

Translation reserve from

foreign operations

 

 

 

Hedging Reserve

Interests Transaction reserve with

non-controlling Interests

 

 

 

Total




? in thousands

For the six months ended June 30, 2020 (unaudited):











Balance as at January 1, 2020

21,998

64,160

12,818

(1,736)

4,356

(1,073)

6,106

106,629

937

107,566

Loss for the period

-

-

(3,472)

-

-

-

-

(3,472)

(797)

(4,269)

Other comprehensive loss for the period

-

-

-

-

(98)

(4,639)

-

(4,737)

(4,448)

(9,185)

Total comprehensive loss for the period

-

-

(3,472)

-

(98)

(4,639)

-

(8,209)

(5,245)

(13,454)

Transactions with owners of the Company,  recognized directly in equity:











Issuance of ordinary shares

1,935

11,253

-

-

-

-

-

13,188

-

13,188

Share-based payments

-

20

-

-

-

-

-

20

-

20

 Balance as at June 30, 2020

23,933

75,433

9,346

(1,736)

4,258

(5,712)

6,106

111,628

(4,308)

107,320

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)











Non-











controlling

Total


Attributable to shareholders of the Company

Interests

Equity




Retained


Translation


Transaction







earnings


reserve from


reserve with





Share

Share

(accumulated

Treasury

foreign

Hedging

non-controlling





capital

Premium

deficit)

shares

operations

Reserve

Interests

Total




? in thousands

For the six months ended June 30, 2019 (unaudited):











Balance as at January 1, 2019

19,980

58,344

758

(1,736)

1,396

(227)

-

78,515

(1,558)

76,957

Loss for the period

-

-

(2,751)

-

-

-

-

(2,751)

(1,647)

(4,398)

Other comprehensive loss for the period

-

-

-

-

1,459

(1,472)

-

(13)

(477)

(490)

Total comprehensive loss for the period

-

-

(2,751)

-

1,459

(1,472)

-

(2,764)

(2,124)

(4,888)

Transactions with owners of the Company, recognized
directly in equity:











Sale of shares in subsidiaries to











non-controlling interests

-

-

-

-

-

-

5,614

5,614

4,899

10,513

Options exercise

8

11

-

-

-

-

-

19

-

19

Share-based payments

-

3

-

-

-

-

-

3

-

3

Balance as at June 30, 2019

19,988

58,358

(1,993)

(1,736)

2,855

(1,699)

5,614

81,387

1,217

82,604

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)




Non-




controlling

Total


Attributable to shareholders of the Company

Interests

Equity

















Translation


Transaction









Reserve from


reserve with




Share

Share

Retained

Treasury

foreign

Hedging

non-controlling


capital

premium

earnings

shares

operations

Reserve

Interests

Total




? in thousands

For the year ended  December 31, 2019 (audited):











Balance as at January 1, 2019

19,980

58,344

758

(1,736)

1,396

(227)

-

78,515

(1,558)

76,957

Profit (loss) for the year

-

-

12,060

-

-

-

-

12,060

(2,276)

9,784

Other comprehensive loss for the year

-

-

-

-

2,960

(846)

-

2,114

(857)

1,257

Total comprehensive loss for the year

-

-

12,060

-

2,960

(846)

-

14,174

(3,133)

11,041

Transactions with owners of the Company,  recognized
directly in equity:











Sale of shares in subsidiaries to non-controlling interests











-

-

-

-

-

-

5,439

5,439

5,374

10,813

Purchase of shares in subsidiaries from non-controlling interests











-

-

-

-

-

-

667

667

254

921

Issuance of ordinary shares

2,010

5,797

-

-

-

-

-

7,807

-

7,807

Options exercise

8

11

-

-

-

-

-

19

-

19

Share-based payments

-

8

-

-

-

-

-

8

-

8

Balance as at December 31, 2019

21,998

64,160

12,818

(1,736)

4,356

(1,073)

6,106

106,629

937

107,566




































 

                         

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Unaudited Interim Statements of Changes in Equity (cont'd)      




Attributable to shareholders of the Company

Non- controlling

Total




Interests

Equity


 

 

 

Share capital

 

 

 

Share premium

 

 

 

Retained earnings

 

 

 

Treasury shares

 

Translation
reserve from

foreign
operations

 

 

 

Hedging Reserve

Interests
Transaction
reserve with

non-controlling
Interests

 

 

 

Total




Convenience translation into US$*

For the six months ended June 30, 2020 (unaudited):











Balance as at January 1, 2020

24,643

71,876

14,360

(1,945)

4,880

(1,202)

6,840

119,452

1,049

120,501

Loss for the period

-

-

(3,890)

-

-

-

-

(3,890)

(892)

(4,782)

Other comprehensive loss for the period

-

-

-

-

(110)

(5,197)

-

(5,307)

(4,983)

(10,290)

Total comprehensive loss for the period

-

-

(3,890)

-

(110)

(5,197)

-

(9,197)

(5,875)

(15,072)

Transactions with owners of the Company,  recognized
directly in equity:











Issuance of ordinary shares

2,168

12,606

-

-

-

-

-

14,774

-

14,774

Share-based payments

-

22

-

-

-

-

-

22

-

22

Balance as at June 30, 2020

26,811

84,504

10,470

(1,945)

4,770

(6,399)

6,840

125,051

(4,826)

120,225


* Convenience translation into US$ (exchange rate as at June 30, 2020: EUR 1 = US$ 1.120)

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Unaudited Interim Statements of Cash Flows



For the three months
ended June 30
,

For the six months
ended June 30
,

For the year ended
December 31,

For the six months
ended June 30


2020

2019

2020

2019

2019

2020


Unaudited

Unaudited

Audited

Unaudited


 

 

? in thousands

Convenience Translation into US$*

Cash flows from operating activities







Profit for the period

(2,404)

(3,429)

(4,269)

(4,398)

9,784

(4,782)

Adjustments for:







Financing expenses, net

697

1,463

1,110

3,127

8,153

1,243

Capital gain

-

-

-

-

(18,770)

-

Depreciation and amortization

721

1,465

1,447

3,043

6,416

1,621

Share-based payment transactions

6

2

20

3

8

22

Share of profits of equity accounted investees 

481

1,133

(850)

(31)

(3,086)

(952)

Payment of interest on loan from an equity accounted investee

-

370

582

370

370

652

Change in trade receivables and other receivables

(461)

(48)

127

(1,744)

403

142

Change in other assets

(19)

-

(234)

(708)

(1,950)

(262)

Change in receivables from concessions project

503

475

704

646

1,329

789

Change in accrued severance pay, net

-

4

-

8

9

-

Change in trade payables

(350)

556

(35)

1,065

461

(39)

Change in other payables

642

638

368

1,054

5,336

412

Income tax expense (tax benefit)

(16)

325

88

514

(287)

99

Income taxes paid

-

-

-

-

(100)

-

Interest received

428

420

869

835

1,719

974

Interest paid

(1,685)

(2,450)

(1,853)

(2,655)

(6,083)

(2,076)

Net cash from (used in) operating activities

(1,457)

924

(1,926)

1,129

3,712

(2,157)

Cash flows from investing activities







Acquisition of fixed assets

(39,866)

(37,230)

(81,280)

(44,519)

(74,587)

(91,054)

Acquisition of subsidiary, net of cash acquired

-

-

-

(1,000)

(1,000)

-

Proceeds from sale of investments

-

-

-

-

34,586

-

Compensation as per agreement with Erez Electricity Ltd.

1,418

-

1,418

-

-

1,589

Repayment of loan by an equity accounted investee

-

-

1,923

-

-

2,154

Proceeds from settlement of derivatives, net

-

-

-

532

532

-

Proceeds (investment) in restricted cash, net

(5)

(5,306)

22,580

(5,219)

(26,003)

25,295

Investment in short term deposit

-

-

-

-

(6,302)

-

Repayment of loan to others

-

3,500

-

3,500

3,912

-

Net cash used in investing activities

(38,453)

(39,036)

(55,359)

(46,706)

(68,862)

(62,016)

Cash flows from financing activities







Repayment of long-term loans

(1,994)

(3,652)

(2,804)

(4,158)

(5,844)

(3,141)

Repayment of Debentures

(4,761)

(4,532)

(26,923)

(4,532)

(9,836)

(30,161)

Cost associated with long term loans

-

-

-

-

(12,218)

-

Proceeds from options

-

-

-

19

19

-

Sale of shares in subsidiaries to non-controlling interests

-

14,062

-

14,062

13,936

-

Acquisition of shares in subsidiaries from non-controlling interests

-

-

-

-

(2,961)

-

Issue of warrants


-

320

-

-

358

Issuance of ordinary shares

-

-

13,188

-

7,807

14,774

Proceeds from long term loans

39,661

41,470

80,584

58,894

59,298

90,275

Proceeds from issuance of Debentures, net

-

-

-

-

22,317

-

Net cash from financing activities

32,906

47,348

64,365

64,285

72,518

72,105








Effect of exchange rate fluctuations on cash and cash equivalents

471

(54)

(357)

(55)

259

(400)

Increase (decrease) in cash and cash equivalents

(6,533)

9,182

6,723

18,653

7,627

7,532

Cash and cash equivalents at the beginning of the period

57,765

46,353

44,509

36,882

36,882

49,861

Cash and cash equivalents at the end of the period

51,232

55,535

51,232

55,535

44,509

57,393


* Convenience translation into US$ (exchange rate as at June 30, 2020: EUR 1 = US$ 1.120)

 

 

Ellomay Capital Ltd. and its Subsidiaries

Reconciliation of Profit (Loss) to EBITDA (in thousands)



For the three months
ended June 30,

For the six months
ended June 30,

For the year
ended December 31,

For the six months
ended June 30,


2020

2019

2020

2019

2019

2020


Unaudited


 

 

? in thousands

Convenience
Translation
into US$*

Net profit (loss) for the period

(2,694)

(3,429)

(4,269)

(4,398)

9,784

(4,782)

Financing expenses, net

782

1,463

1,110

3,127

8,153

1,243

Taxes on income

(18)

325

88

514

(287)

99

Depreciation

808

1,465

1,447

3,043

6,416

1,621

EBITDA

(1,122)

(176)

(1,624)

2,286

24,066

(1,819)


* Convenience translation into US$ (exchange rate as at June 30, 2020: EUR 1 = US$ 1.120)

 

 

Information for the Company's Debenture Holders

Pursuant to the Deeds of Trust governing the Company's Series B and C Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 7, 2020.

Net Financial Debt

As of June 30, 2020, the Company did not have a Net Financial Debt, as the calculation of Net Financial Debt (as such term is defined in the Deeds of Trust of the Company's Debentures), resulted in a negative amount (i.e., an excess of assets over liabilities) of approximately ?(15.4) million (consisting of approximately ?174.2 million of short-term and long-term debt from banks and other interest bearing financial obligations and approximately ?44.7 million in connection with the Series B Debentures issuance (in March 2017) and the Series C Debentures issuance (in July 2019), net of approximately ?59.9 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately ?174.4* million of project finance and related hedging transactions of the Company's subsidiaries).

_____________________________

* The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies). The minority shareholders' loans were not included in the project finance amount in previous calculations due to an oversight, despite such loans' terms and characteristics as "financing of projects" as set forth in the definition of Net Financial Debt in the Deeds of Trust governing the Debentures. The Company updated its calculations of Net Financial Debt and of the financial covenants based on Net Financial Debt for the recent four quarters, amending the oversight, and provided them to the Trustee of the Debentures. Based on the updated calculations, the calculation of Net Financial Debt of the Company as of June 30, 2019, September 30, 2019, December 31, 2019 and March 31, 2020 resulted in the following: ?(6.3) million, ?(4.3) million, ?18.2 million and ?(17.3) million, respectively. The updated financing of projects amount for such periods is ?136.2 million, ?136.5 million, ?101 million and ?139.5 million, respectively. The change in calculation did not affect the Company's fulfillment of the financial covenants as of such dates.  The change in calculation also did not affect the Company's fulfillment of the financial covenants as of June 30, 2020, as the Net Financial Debt excluding the minority shareholders' loans as of June 30, 2020 was ?33.7 million (based on a financing of projects amount of ?125.3 million).

Information for the Company's Series B Debenture Holders

The following is an internal pro forma consolidated statement of financial position of the Company as at June 30, 2020. This information is required under the Series B Deed of Trust in connection with the adoption of IFRS 16 "Leases" by the Company and provides the consolidated statement of financial position of the Company as of the date set forth below after elimination of the effects of adoption of IFRS 16. Based on the pro forma statement of financial position, the ratio of the Company's equity (which the Company calculated in line with the definition of Balance Sheet Equity in the Series B Deed of Trust) to balance sheet as at June 30, 2020 was 31.1%.

 

 

 

Unaudited Internal Pro Forma Statement of Financial Position




June 30,



2020



Unaudited



Pro Forma

? in thousands

Assets



Current assets



Cash and cash equivalents


51,232

Marketable securities


2,226

Short term deposits


6,439

Receivable from concession project


1,486

Trade and other receivables


4,790



66,173

Non-current assets



Investment in equity accounted investee


32,165

Advances on account of investments


882

Receivable from concession project


26,173

Fixed assets


194,521

Intangible asset


4,857

Restricted cash and deposits


10,275

Deferred tax


5,954

Long term receivables


5,305

Long term receivables


209

Derivatives


280,341

Total assets


346,514




Liabilities and Equity



Current liabilities



Current maturities of long term loans


7,075

Debentures


4,592

Trade payables


1,730

Other payables


5,185



18,582

Non-current liabilities



Long-term loans


157,617

Debentures


40,087

Deferred tax


6,963

Other long-term liabilities


1,289

Derivatives


14,152



220,108

Total liabilities


238,690




Equity



Share capital


23,933

Share premium


75,433

Treasury shares


(1,736)

Transaction reserve with non-controlling Interests


6,106

Reserves


(1,454)

Accumulated deficit


9,850

Total equity attributed to shareholders of the Company


112,132

Non-Controlling Interest


(4,308)

Total equity


107,824

Total liabilities and equity


346,514

 

 

 

Information for the Company's Series C Debenture Holders

The Deed of Trust governing the Company's Series C Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of June 30, 2020, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's shareholders' equity was ?107.5 million and (ii) the Company did not have a Net Financial Debt. In the event the Company does not have a Net Financial Debt the calculation of the two covenants that are based on Net Financial Debt (i.e., the ratio of the Company's Net Financial Debt to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) and the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(1)), becomes irrelevant and the Company is therefore in compliance with such covenants.

______________________________________________

 (1) The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef project, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

The following is a reconciliation between the Company's net profit and the Adjusted EBITDA for the four-quarter period ended June 30, 2020*:

 


For the four
quarter period
ended June 30,
2020


Unaudited


? in thousands

Net profit for the period

9,913

Financing expenses, net

6,136

Taxes on income

(713)

Depreciation

4,820

Adjustment to revenues of the Talmei Yosef project due to calculation based on the
fixed asset model

2,889

Share-based payments

25

Adjusted EBITDA as defined the Series C Deed of Trust

23,070

___________________________________

* As noted above, the Company is in compliance with the covenant with respect to the ratio of Net Financial Debt to Adjusted EBITDA as the Company does not have a Net Financial Debt as of the end of the period. Therefore, the Adjusted EBITDA calculation above is provided for convenience and consistency purposes only.

Contact:

Kalia Weintraub
CFO
Tel: +972 (3) 797-1111
Email: [email protected]

 

SOURCE Ellomay Capital Ltd


These press releases may also interest you

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:40
NuRAN Wireless Inc. ("NuRAN" or the "Company") , a leading supplier of mobile and broadband wireless infrastructure solutions, is pleased to announce the execution of a two-year term loan facility agreement (the "Loan...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
HCA Healthcare, Inc. today announced financial and operating results for the first quarter ended March 31, 2024. Key first quarter metrics (all percentage changes compare 1Q 2024 to 1Q 2023 unless otherwise noted): Revenues totaled $17.339...

at 07:15
PowerBand Solutions Inc. ("PowerBand", "PBX" or the "Company"), a comprehensive trading and financing technology platform transforming the online experience to sell, trade, lease, and finance vehicles, is pleased to...

at 07:00
Village Farms International, Inc. ("Village Farms" or the "Company") today announced it will host a conference call to discuss its first quarter 2024 financial results on Wednesday, May 8, 2024, at 8:30 a.m. ET. Participants can access the...



News published on and distributed by: